FDA Inspection 1221607 — Peter Tenke, M.D., PhD, Principal Investigator
The FDA completed an inspection of Peter Tenke, M.D., PhD, Principal Investigator on Oct 19, 2023 in Budapest X. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Budapest X (Hungary)
Additional Details
Clinical Investigator (CI)